# FDA Warning Letter: Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.
> 2024-11-19 · Center for Drug Evaluation and Research (CDER) · `ad792514578f397e`
## Letter
- **Company:** Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.
- **Posted Date:** 2024-11-19
- **Letter Issue Date:** 2024-10-30
- **Issuing Office:** Center for Drug Evaluation and Research (CDER)
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*